Turning Point Brands, Inc. (TPB) Stock Analysis and Metrics

Turning Point Brands

NYSE: TPB

$85.79 ▼ -1.58 (-1.80%)

At close: Jul 2, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap1.68 Bn

P/E30.34

P/S3.50

Div. Yield0.00

ROIC (Qtr)0.00

Total Debt (Qtr)293.89 Mn

Revenue Growth (1y) (Qtr)16.76

Add ratio to table…

About

Turning Point Brands, Inc. is a manufacturer, marketer and distributor of branded consumer products that serve adult consumers. The company focuses on the alternative smoking accessories and other tobacco products markets, offering items such as rolling papers, tubes, cigars, smokeless tobacco and nicotine pouch products.

The company generates revenue by selling its own branded products and through distribution agreements with third parties. Core products include rolling papers, tubes and related accessories; finished cigars and make your own cigar wraps; moist snuff tobacco; FRE and ALP modern oral nicotine pouches; and loose leaf chewing tobacco. Revenue is derived from sales to approximately nine hundred distributors and six hundred secondary wholesarers in the United States, which together supply roughly two hundred twenty thousand retail outlets across North America, as well as from an expanding electronic commerce business.

The company operates through the following segments: Zig Zag products segment and Stoker’s products segment.

• Zig Zag products segment: the segment markets and distributes rolling papers, tubes and related items; finished cigars and make your own cigar wraps; and other smoking accessories. It also holds a majority interest in a Canadian marketing and distribution firm that focuses on cannabis accessories, tobacco and alternative products, and sources its cigarette paper from RTI under a long term supply agreement. The segment has expanded into hemp wraps, natural leaf wraps and paper cones to address evolving consumer preferences.

• Stoker’s products segment: the segment manufactures and markets moist snuff tobacco; contracts for and markets FRE and ALP modern oral nicotine pouches; and contracts for and markets loose leaf chewing tobacco. Moist snuff production occurs at the company’s facility in Dresden Tennessee using a proprietary process, while loose leaf tobacco is sourced from Swedish Match under a longstanding agreement. The segment also participates in a joint venture with ALP Supply Co LLC to develop and distribute nicotine pouch products in various strengths.

Turning Point Brands, Inc. holds a leading position in its core markets due to the strength of its iconic brands and its extensive distribution network. The Zig Zag brand is the number one premium rolling paper in the United States with approximately thirty three percent market share and is also the top maker of make your own cigar wraps. The Stoker’s brand is the number one discount and overall chewing tobacco brand with roughly thirty four percent share and a growing presence in the moist snuff category. The company competes with larger tobacco firms such as Altria Group, British American Tobacco, Swedish Match and Swisher International, but maintains advantages through strong brand recognition, low cost asset light operations, deep regulatory expertise and a flexible supply chain that enables rapid product introduction.

The company serves adult consumers through a wide variety of retail channels including convenience stores, tobacco outlets, food stores, mass merchandisers, drug stores, headshops, dispensers and electronic commerce platforms. Products reach these outlets via approximately nine hundred distributors and six hundred secondary wholesalers in the United States. In 2025 no single customer accounted for ten percent or more of net sales, indicating a diversified customer base.

Investment Thesis

▲ Bull case

Turning Point Brands is well-positioned to capitalize on the generational shift toward modern oral nicotine products, with Modern Oral accounting for 42% of total net sales in Q1 FY26, up from 21% a year ago, signaling a rapid and sustained shift in consumer preference toward nicotine pouches. The company’s confidence in achieving double-digit market share by decade-end is grounded in strong product performance, as evidenced by 133% year-over-year net sales growth for Modern Oral, driven by repeat purchasing behavior and brand loyalty for FRE and ALP. Management’s focus on securing distribution in larger regional and national convenience chains—projected to increase store count by 70% by end of 2026—provides a structural advantage, as brick-and-mortar expansion is proving faster than anticipated, particularly for ALP, which has transitioned from D2C strength into retail more quickly than expected. This dual-brand strategy allows TPB to target distinct consumer segments, reducing cannibalization risk and increasing shelf appeal, while early retailer feedback indicates strong appreciation for having both brands in portfolio, enhancing negotiation leverage and incremental SKU acceptance. The TKO partnership with UFC, Zuffa Boxing, and PBR represents a high-impact, under-promoted catalyst that extends beyond traditional tobacco advertising channels, directly engaging adult consumers in lifestyle and sports environments where brand credibility and awareness can be built authentically; early execution of events under this partnership has already generated consumer excitement, suggesting long-term returns on brand-building investments that are currently expensed but will drive future pricing power and margin expansion. Furthermore, the Louisville manufacturing facility, while not yet at scale, is strategically positioned to reduce long-term unit costs by localizing production, mitigating tariff and freight exposure, and improving supply chain control—benefits that will flow through to gross margins as domestic inventory cycles through the P&L, with management targeting 70% gross margins in Modern Oral by decade-end, a level that would significantly enhance profitability as scale is achieved. Finally, the company’s disciplined capital allocation, including $80–105 million in sales and marketing investments for 2026, is front-loaded but designed to yield attractive long-term returns, as these costs are expected to become a smaller percentage of sales over time as the consumer base grows and repeat purchasing drives annuity-like value in the nicotine pouch category.

Turning Point Brands is well-positioned to capitalize on the generational shift toward modern oral nicotine products, with Modern Oral accounting for 42% of total net sales in Q1 FY26, up from 21% a year ago, signaling a rapid and sustained shift in consumer preference toward nicotine pouches. The company’s confidence in achieving double-digit market share by decade-end is grounded in strong product performance, as evidenced by 133% year-over-year net sales growth for Modern Oral, driven by repeat purchasing behavior and brand loyalty for FRE and ALP. Management’s focus on securing distribution in larger regional and national convenience chains—projected to increase store count by 70% by end of 2026—provides a structural advantage, as brick-and-mortar expansion is proving faster than anticipated, particularly for ALP, which has transitioned from D2C strength into retail more quickly than expected. This dual-brand strategy allows TPB to target distinct consumer segments, reducing cannibalization risk and increasing shelf appeal, while early retailer feedback indicates strong appreciation for having both brands in portfolio, enhancing negotiation leverage and incremental SKU acceptance. The TKO partnership with UFC, Zuffa Boxing, and PBR represents a high-impact, under-promoted catalyst that extends beyond traditional tobacco advertising channels, directly engaging adult consumers in lifestyle and sports environments where brand credibility and awareness can be built authentically; early execution of events under this partnership has already generated consumer excitement, suggesting long-term returns on brand-building investments that are currently expensed but will drive future pricing power and margin expansion. Furthermore, the Louisville manufacturing facility, while not yet at scale, is strategically positioned to reduce long-term unit costs by localizing production, mitigating tariff and freight exposure, and improving supply chain control—benefits that will flow through to gross margins as domestic inventory cycles through the P&L, with management targeting 70% gross margins in Modern Oral by decade-end, a level that would significantly enhance profitability as scale is achieved. Finally, the company’s disciplined capital allocation, including $80–105 million in sales and marketing investments for 2026, is front-loaded but designed to yield attractive long-term returns, as these costs are expected to become a smaller percentage of sales over time as the consumer base grows and repeat purchasing drives annuity-like value in the nicotine pouch category.

▼ Bear case

Despite strong Modern Oral growth, Turning Point Brands faces significant headwinds that the market may be overlooking, beginning with the persistent softness in the Zig-Zag segment, where net sales declined 22% year-over-year in Q1 FY26 due to lower U.S. papers and wraps shipments, indicating structural challenges in legacy smoking accessories that are not being offset by innovation alone, as evidenced by only modest acceleration in Natural Leaf Flat Wraps through targeted merchandising—suggesting that Zig-Zag’s decline may be more enduring than management implies, eroding a historically reliable cash flow stream that has funded growth investments. The company’s gross margin declined 100 basis points year-over-year to 55%, driven by Modern Oral’s lower margin profile and the impact of tariffs on Stoker’s, which saw gross margin drop 350 basis points to 54%, revealing that even the heritage business is vulnerable to macroeconomic pressures, and that Modern Oral’s current margin dilution is not merely a temporary investment phase but a structural characteristic of scaling in a competitive, promotion-heavy category where slotting fees and trade spend remain elevated. While management expects margins to approach 70% in Modern Oral by decade-end, this assumption hinges on achieving significant scale and reducing trade spend as a percentage of sales—a risky projection given that category leaders continue to invest heavily in promotions and shelf placement, and TPB’s current gross-to-net sales gap (Modern Oral gross sales up 167% vs. net sales up 133%) indicates substantial contra revenue investments that may not decline as anticipated, especially as chain expansion increases slotting fee burdens. The $80–105 million sales and marketing budget for 2026 represents a significant and sustained increase in OpEx, and while management frames it as disciplined, the wide EBITDA guidance range ($70–90 million) reflects uncertainty in leveraging these investments effectively, with upside tied to unproven catalysts like the TKO partnership, which remains early-stage and lacks clear metrics on ROI or incremental sales lift, making it difficult to justify as a reliable earnings driver. Furthermore, the PMTA process, though not discussed in detail, remains an unquantified overhang; management’s refusal to comment on timing or progress suggests potential delays or regulatory hurdles that could disrupt product availability or force costly reformulations, particularly for FRE and ALP, and while only two product lines are currently under review, any adverse outcome could trigger broader scrutiny or reclassification risks in the evolving regulatory landscape for oral nicotine products. Finally, the company’s reliance on legacy segments for cash flow to fund Modern Oral investments is increasingly tenuous, as Stoker’s growth is being driven by MST share gains amid declining loose leaf, a shift that may not be sustainable, and Zig-Zag’s weakening performance reduces the buffer available to absorb missteps in the Modern Oral transition, leaving TPB with less financial flexibility than its optimistic guidance assumes.

Despite strong Modern Oral growth, Turning Point Brands faces significant headwinds that the market may be overlooking, beginning with the persistent softness in the Zig-Zag segment, where net sales declined 22% year-over-year in Q1 FY26 due to lower U.S. papers and wraps shipments, indicating structural challenges in legacy smoking accessories that are not being offset by innovation alone, as evidenced by only modest acceleration in Natural Leaf Flat Wraps through targeted merchandising—suggesting that Zig-Zag’s decline may be more enduring than management implies, eroding a historically reliable cash flow stream that has funded growth investments. The company’s gross margin declined 100 basis points year-over-year to 55%, driven by Modern Oral’s lower margin profile and the impact of tariffs on Stoker’s, which saw gross margin drop 350 basis points to 54%, revealing that even the heritage business is vulnerable to macroeconomic pressures, and that Modern Oral’s current margin dilution is not merely a temporary investment phase but a structural characteristic of scaling in a competitive, promotion-heavy category where slotting fees and trade spend remain elevated. While management expects margins to approach 70% in Modern Oral by decade-end, this assumption hinges on achieving significant scale and reducing trade spend as a percentage of sales—a risky projection given that category leaders continue to invest heavily in promotions and shelf placement, and TPB’s current gross-to-net sales gap (Modern Oral gross sales up 167% vs. net sales up 133%) indicates substantial contra revenue investments that may not decline as anticipated, especially as chain expansion increases slotting fee burdens. The $80–105 million sales and marketing budget for 2026 represents a significant and sustained increase in OpEx, and while management frames it as disciplined, the wide EBITDA guidance range ($70–90 million) reflects uncertainty in leveraging these investments effectively, with upside tied to unproven catalysts like the TKO partnership, which remains early-stage and lacks clear metrics on ROI or incremental sales lift, making it difficult to justify as a reliable earnings driver. Furthermore, the PMTA process, though not discussed in detail, remains an unquantified overhang; management’s refusal to comment on timing or progress suggests potential delays or regulatory hurdles that could disrupt product availability or force costly reformulations, particularly for FRE and ALP, and while only two product lines are currently under review, any adverse outcome could trigger broader scrutiny or reclassification risks in the evolving regulatory landscape for oral nicotine products. Finally, the company’s reliance on legacy segments for cash flow to fund Modern Oral investments is increasingly tenuous, as Stoker’s growth is being driven by MST share gains amid declining loose leaf, a shift that may not be sustainable, and Zig-Zag’s weakening performance reduces the buffer available to absorb missteps in the Modern Oral transition, leaving TPB with less financial flexibility than its optimistic guidance assumes.

Geographical Breakdown of Revenue (2025)

Peer Comparison

Companies in the Tobacco

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	MO	Altria Group, Inc.	66.91 Bn	8.31	2.85	24.60 Bn
2	RLX	RLX Technology Inc.	2.38 Bn	13.14	3.53	0.02 Bn
3	TPB	Turning Point Brands, Inc.	1.68 Bn	30.34	3.50	0.29 Bn
4	UVV	Universal Corp /Va/	1.30 Bn	23.30	0.45	0.62 Bn
5	ISPR	Ispire Technology Inc.	0.07 Bn	-1.91	0.73	0.00 Bn
6	RYM	RYTHM, Inc.	0.05 Bn	7.93	1.82	0.01 Bn
7	GNLN	Greenlane Holdings, Inc.	0.01 Bn	-0.10	2.88	-
8	VPRB	VPR Brands, LP.	0.00 Bn	4.43	1.41	0.00 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password